GLP-1 Receptor Agonist Use Does Not Increase Insulin Discontinuation With Type 2 Diabetes

THURSDAY, July 16, 2026-- For veterans with type 2 diabetes (T2D) receiving basal insulin therapy, the addition of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) does not increase the rate of insulin discontinuation compared with other...